Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Zebularine improved skin structure but delayed wound healing in diabetic mice.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Olanzapine helped a man who thought he had bugs on his skin.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Calcipotriene ointment improved a child's skin condition known as En coup de sabre.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

CS12192 effectively treats alopecia areata with better safety than current options.

Baricitinib was effective in treating both early and late onset alopecia areata.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Clascoterone safely promotes hair growth similar to minoxidil.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

A new microneedle patch effectively and safely treats alopecia areata.

These medications for BPH have known risks and may have new side effects.

Crisaborole may help regrow hair in children with alopecia areata.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.